L'Oreal USA Inc.
Division of L'Oreal SA
Latest From L'Oreal USA Inc.
The Ninth Circuit will hear arguments from L’Oreal and a plaintiff who alleges the firm’s RevitaLift products are unlawfully marketed drugs, following the case’s dismissal in July on federal preemption grounds. In a neighboring California district, Beiersdorf intends to seek summary judgment in five-year-old litigation of a similar design, concerning Nivea Skin Firming Hydration Body Lotion.
Even if plaintiffs’ allegations are true and significant amounts of L'Oreal Paris and Maybelline pump-dispensed liquid makeup cannot be accessed by consumers due to the company's packaging design, plaintiffs’ deception claims still are preempted by federal statutes, a US district judge says, dismissing the proposed class action in New York’s Southern District.
There’s a growing body of scientific evidence linking cannabidiol to benefits of interest to beauty industry players, but if a company’s CBD ingredient differs from the substance studied, that could be grounds for a false-advertising complaint. Venable partner Todd Halpern discusses.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.